Pharmacology & Toxicology

← Back to Domain-Specific Abstractions by Origin Domain

26 domain-specific abstractions whose origin domain is Pharmacology & Toxicology. They span 23 subdomains — sort by that column to group them, or click any subdomain to filter to it.

Abstraction	Subdomain	Description
Absorption (pharmacology)	Pharmacokinetics	Absorption is the journey of a drug travelling from the site of administration to the site of action.
Adverse Event Prediction	Pharmaceutical Safety SciencePreclinical to Clinical Safety Translation	Infer which clinically observable harms may emerge, for which people and exposures, from an investigational drug before sufficient human safety observations exist, while preserving uncertainty, translation assumptions, and later validation.
Aspect Qualifier	Biomedical Indexing	Attach a controlled modifier from a small closed list to a subject descriptor so the indexed claim names a topic in one specific sense — Aspirin/adverse effects, not aspirin-as-such — factoring topic from aspect to gain precision without vocabulary bloat.
Biodistribution	Pharmacokinetics	Biodistribution is a method of tracking where compounds of interest travel in an experimental animal or human subject.
Cell culture assay	In Vitro Cytotoxicity TestingBiocompatibility Testing	A controlled in-vitro exposure of cultured cells to a material or extract, using validated biological endpoints and controls to assess cytotoxic potential within stated limits.
Context-sensitive half-life	Pharmacokinetics	Context-sensitive half-life or context sensitive half-time is defined as the time taken for blood plasma concentration of a drug to decline by one half after an infusion designed to maintain a steady state (i.e. a constant plasma concentration) has been stopped.
Controlled Descriptor	Biomedical Indexing	Substitute one governed preferred term from a maintained vocabulary for whatever words a resource used, so every resource on a topic retrieves through the same descriptor regardless of the author's surface phrasing.
Drug Accumulation Ratio	Clinical Pharmacokinetics	A pharmacokinetic ratio comparing exposure during a dosing interval at repeated-dose steady state with exposure during the corresponding interval after a single dose, under a declared calculation convention.
Efficacy	Receptor Pharmacology	Separate the maximum effect a drug can produce at its target under full engagement (the ceiling, E_max) from the dose needed to approach it (potency, EC50), rooting that ceiling in the agent's intrinsic activity so a ceiling problem cannot be fixed by escalation.
Elimination Pathway	Pharmacokinetics	Classify a drug or toxin by the dominant biochemical route through which the body removes it — hepatic metabolism, renal excretion, or a minor exit — so that clearance rate, interaction risks, and toxicity failure modes can be read off the route rather than memorized per substance.
Entry Term Alias	Controlled Vocabulary Alias Routing	Curate a non-preferred surface form — synonym, abbreviation, colloquialism, superseded name — as a silent, non-indexing bridge that routes many-to-one to a canonical descriptor, so users arrive at one place however they name the concept.
Inverse Agonist	Receptor Pharmacology	A ligand that binds a receptor with constitutive activity and selectively stabilizes its inactive conformation, driving output below the unliganded baseline — occupying the negative end of a signed efficacy axis, distinct from an antagonist that merely blocks.
Lipinski's Rule of Five	Oral Drug DiscoveryPhysicochemical Property Assessment	Flag possible oral absorption or permeation difficulty from four empirical molecular-property thresholds, without treating the alert as a verdict.
NOAEL (No Observed Adverse Effect Level)	—	Anchor a substance's acceptable human exposure at the highest tested dose showing no observed adverse effect, treating that dose as a fact about the study's design that brackets — but does not pin — the unknown biological threshold.
P-i mechanism	Drug Immunology	The p-i mechanism explains drug hypersensitivity through direct off-target interaction between a drug and immune receptors that activates T cells.
Partial Agonist	Receptor Pharmacology	A ligand that binds and activates a receptor but with intrinsic efficacy between zero and one, so even at full occupancy it produces a submaximal response — acting as an agonist when alone and a functional antagonist when a full agonist is present.
Pharmacodynamics	Clinical PharmacologyDrug Action	Pharmacodynamics studies and models what a drug does to a biological system by relating concentration or exposure at sites of action to biochemical, physiological, therapeutic, and toxic effects over time.
Polypharmacy	Clinical Pharmacology	Shift the unit of clinical attention from the single prescription to the whole regimen, sorting the combined risk of concurrent drugs into three channels — pharmacokinetic collisions, pharmacodynamic summation, and the prescribing cascade — under one appropriate-versus-problematic binary.
Receptor antagonist	Receptor PharmacologyPharmacodynamics	A receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist.
Retro Screening	Computational Target Fishing	Hold a compound query fixed, compare it across many target-associated representations, and prioritize putative biological targets for separate testing.
Reuptake inhibitor	Neuropharmacology	An agent that reduces transporter-mediated removal of a signaling molecule, altering its extracellular or vesicular availability according to the transporter and inhibition site involved.
Tachyphylaxis	PharmacodynamicsDrug Tolerance	Tachyphylaxis (from Ancient Greek , 'rapid', and , 'protection') is a medical term describing an acute, sudden decrease in response to a drug after its administration (i.e., a rapid and short-term onset of drug tolerance).
Targeted Drug Delivery	Drug DeliveryPharmaceutics	A delivery design that coordinates formulation, transport, localization, and release so a therapeutic payload achieves preferential exposure at a specified biological target relative to off-target sites.
Tissue selectivity	Drug Distribution and Tissue Response	A drug's disproportionate concentration or effect in some tissues rather than others, arising from distribution barriers, transport, metabolism, receptor context, local activation, or biased pharmacodynamic response.
Toxicokinetics	ToxicologyPharmacokinetics	Toxicokinetics (often abbreviated as 'TK') is the description of both what rate a chemical will enter the body and what occurs to excrete and metabolize the compound once it is in the body.
Volume of Distribution	PharmacokineticsDrug Distribution	An apparent pharmacokinetic volume defined by drug amount in the body divided by concentration in a specified blood or plasma reference space, quantifying distribution outside that sampled space without naming an anatomical container.